Overview

Clinical Trial to Evaluate the Efficacy and Safety of CKD-342

Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
Clinical Trial to Evaluate the Efficacy and Safety of CKD-342
Phase:
Phase 3
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Treatments:
Levocabastine
Mometasone Furoate